3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Genitourinary
1
Breast
1
Conditions
Prostatic Neoplasms
3
Multiple Myeloma
2
Breast Neoplasms
2
Patient Compliance
1
Pain
1
Osteolysis
1
Bone Neoplasms
1
Interventions
Zoledronic Acid
2
Vincristine
2
Irinotecan
2
Gemcitabine
2
Etoposide
2
Doxorubicin
2
Cyclophosphamide
2
saracatinib
1
robatumumab
1
radium Ra 223 dichloride
1
liposomal doxorubicin
1
cc-486
1
Temozolomide
1
Taxes
1
Standard of Care
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Practice Guidelines as Topic
1
Patient Reported Outcome Measures
1
Palliative Care
1
Paclitaxel
1
Observation
1
Molecular Diagnostic Techniques
1
Methods
1
Lomustine
1
Injections
1
Immunotherapy
1
Ifosfamide
1
Genetic Testing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Clodronic Acid
×
Genitourinary
×
Clear all
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled